Go offline with the Player FM app!
Ep 112 - Lizard Lips and Sunken Cheeks: Demystifying Ozempic
Fetch error
Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on October 28, 2024 06:41 ()
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 359930663 series 2841142
In today's episode, Harini and Megan discuss the recent pop-culture fascination in weight loss drugs. Specifically Ozempic, Wegovy, and generic semaglutide. What are these drugs, what do they do, and why have they (allegedly) taken the celebrity world by storm? Are these drugs legitimately controversial or has the online zeitgeist created artificial contention? We have answers.
See omnystudio.com/listener for privacy information.
101 episodes
Fetch error
Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on October 28, 2024 06:41 ()
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 359930663 series 2841142
In today's episode, Harini and Megan discuss the recent pop-culture fascination in weight loss drugs. Specifically Ozempic, Wegovy, and generic semaglutide. What are these drugs, what do they do, and why have they (allegedly) taken the celebrity world by storm? Are these drugs legitimately controversial or has the online zeitgeist created artificial contention? We have answers.
See omnystudio.com/listener for privacy information.
101 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.